Overview

Low-dose Aspirin Therapy for Esophageal Cancer

Status:
Withdrawn
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the survival benefit of low-dose aspirin use for stage II-III esophageal cancer patients.
Phase:
Phase 3
Details
Lead Sponsor:
Zhejiang University
Treatments:
Aspirin